New directions in metabolic syndrome diagnosis: assessment of vascular endothelial growth factor, pentraxin-3 and transforming growth factor beta levels
Open Access
- 22 December 2019
- journal article
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 18 (6), 57-61
- https://doi.org/10.15829/1728-8800-2019-6-57-61
Abstract
В статье представлены результаты отечественных и зарубежных клинических исследований, посвященных изучению уровня маркеров ангиогенеза — сосудистый эндотелиальный фактор роста, пентраксин-3 и трансформирующий фактор роста бета, у пациентов с метаболическим синдромом.This publication has 45 references indexed in Scilit:
- Prevalence of metabolic syndrome in 25—45-year-old Novosibirsk dwellersTerapevticheskii arkhiv, 2016
- The prevalence of metabolic syndrome in a sample of residents of Kaliningrad"Arterial’naya Gipertenziya" ("Arterial Hypertension"), 2016
- Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian PopulationInternational Journal of Medical Sciences, 2016
- A Comprehensive Review on Metabolic SyndromeCardiology Research and Practice, 2014
- Prevalence, components, and correlates of metabolic syndrome (MetS) among elderly MuscovitesArchives of Gerontology and Geriatrics, 2011
- Harmonizing the Metabolic SyndromeJournal of the American College of Cardiology, 2009
- First Nationwide Study of the Prevalence of the Metabolic Syndrome and Optimal Cutoff Points of Waist Circumference in the Middle EastDiabetes Care, 2009
- The metabolic syndrome—a new worldwide definitionThe Lancet, 2005
- Predictors of the Incident Metabolic Syndrome in AdultsDiabetes Care, 2004
- Clustering of Metabolic Factors and Coronary Heart DiseaseArchives of Internal Medicine, 1999